Literature DB >> 24373456

Iron chelation in MDS: still a controversial issue.

Judith Neukirchen1.   

Abstract

Entities:  

Keywords:  Iron chelation; MDS; Survival

Mesh：

Substances：

Year:  2013        PMID： 24373456     DOI： 10.1016/j.leukres.2013.12.004

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

Review 1.  Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.

Authors:  Yisu Gu; Lise J Estcourt; Carolyn Doree; Sally Hopewell; Paresh Vyas
Journal:  Cochrane Database Syst Rev       Date:  2015-10-05

2.  Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS).

Authors:  Annika Kasprzak; Kathrin Nachtkamp; Norbert Gattermann; Ulrich Germing
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.575

3.  Ferritin level changes and erythroid improvement in a group of adult polytransfused patients treated with Deferasirox.

Authors:  Andrada Viorica Parvu; Anca Bojan; Laura Urian; Tunde Torok; Iulia Andrea Zsoldos; Mihaela Iancu
Journal:  Clujul Med       Date:  2018-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.